Drug Type Monoclonal antibody |
Synonyms humanized monoclonal antibody directed against human zinc-regulated transporter-like, iron-regulated transporter-like protein 12, AP13, APL 9796 + [1] |
Target |
Mechanism SLC39A12 blockers(solute carrier family 39 member 12 blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Arterial Hypertension | Phase 1 | AU | 27 Feb 2024 |